Project Number PTCG-20-704203 Agency/Funding Organization Alzheimer's Association Funding Year 2020 View Full Project Details for Aromatase inhibition in Alzheimer's disease: Phase 2 study Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) l. Growth Factors and Hormones Researcher and Organization Principal Investigator BIEGON, ANAT Principal Investigator First Name ANAT Principal Investigator Last Name BIEGON Awardee Organization The Research Foundation of SUNY- SUNY at Stony Brook Awardee State New York, N.Y. Contact PI Country United States Project Detail FY Overall Cost $1,982,718 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Alzheimer Association
